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Mark s. brown 
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Jonathan a. Paul 
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Maine’S HiGH-RiSK inFanTS
The Maine Infant Follow-Up Project is a research-
based effort to accelerate early identification of devel-
opmental risk for infants whose mothers use drugs or 
alcohol. These infants are at high risk for neurodevel-
opmental disorders, and early identification will 
enable early-early intervention. Targeted interven-
tions will increase the chance for children to catch up 
developmentally during the period of most rapid 
brain growth in the first three years of life.    
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Maternal and child health is profoundly affected by Maine’s regional landscape of intergenera-
tional rural poverty and limited health care access. 
economic and social disadvantage is all too common in 
Maine families and can derail the path to normal child 
development. Maine’s rate of infant mortality in the 
first year is high, but similar to U.S. rural states, with 
leading causes being congenital anomalies, prematurity, 
sudden infant death syndrome (SiDS), and pregnancy 
and delivery complications. 
 according to the web-based injury Statistics 
Query and Reporting System (wiSQaRS) of the U.S. 
centers for Disease control and Prevention (www.cdc.
gov/injury/wisqars/), SiDS in Maine represents 10 
percent of all infant deaths compared to only 5.4 
percent in the northeast region. Because of the known 
association of SiDS and prenatal alcohol and drug 
addiction (Hunt and Hauck 006), Maine’s elevated 
SiDS rate may reflect an acquired brain injury that is 
driven largely by poor maternal health, lifestyle, and 
economic adversity.    
although Maine has implemented policy changes 
to address the leading cause of infant death (i.e., 
congenital anomalies) with mandated statewide 
screening for a host of genetic and metabolic disorders 
at the time of birth, at present there is no public policy 
that mandates screening for long-term consequences of 
prenatal poverty-related risk factors (e.g., alcohol, 
tobacco, abuse of opiates and other substances, lack of 
prenatal care, malnutrition, and domestic abuse). 
Maine’s spiraling need for services for developmental 
disabilities and special education (Maine Department 
of education 007) poses a crisis of care for early iden-
tification of developmental and behavioral disorders 
related to maternal addiction. 
Regionally, northeastern Maine families show 
exceptionally low socioeconomic status (e.g., poor 
employment and education achievement; receipt of 
public assistance and Medicaid) that is correlated with 
alcohol, tobacco, and drug addiction (Hayes et al. 
00; Troese et al. 008). During pregnancy and 
immediately after birth, unregulated drug and alcohol 
exposure of the developing child is probabilistically 
(dependent on genetic susceptibility, dose, and timing) 
related to neurological damage (e.g., poor respiratory 
and cardiac function associated with prematurity, and 
cognitive and motor deficits 
associated with oxygen depriva-
tion), leading to developmental 
disabilities later in childhood. 
PReScRiPTion oPiaTe 
ePiDeMic anD PRenaTal 
eXPoSUReS
an increasingly large group of Maine infants are being 
exposed to prescription opiates 
as addiction reaches epidemic 
proportions statewide. Hospital 
admissions for prescription drug 
abuse increased 06 percent 
between 004 and 008 (Maine 
Department of Health and 
Human Services 009). in the 
most recent national Survey 
on Drug Use and Health in 
Maine (006–007), 4.6 percent 
of those 1 or older (5,000 
people) reported having used 
pain relievers nonmedically in the past year (Hughes, 
Sathe and Spagnola 009). young adults of childbearing 
age constitute the largest group of opiate-addicted 
patients, with 9 percent of the 500 women in treat-
ment in acadia Hospital’s narcotics Treatment Program 
(nTP) in Bangor being of childbearing age, and approx-
imately 15 percent being pregnant at any given time. 
The standard of care for pregnant women with 
opiate addiction is methadone maintenance through 
enrollment in a narcotics treatment program. careful 
dosing of methadone matches the increasing metabolic 
demands of the growing fetus. in contrast, untreated 
opiate abuse (typically in a background of co-occurring 
maternal tobacco and alcohol abuse) exposes the fetus 
to repeated binge and withdrawal episodes responsible 
for high rates of in utero fetal death (oei and lui 
007). after birth, opiate-dependent infants are at high 
risk for numerous adverse effects, including a 
protracted withdrawal process. The severity of with-
drawal is compounded by maternal psychiatric diag-
nosis requiring antidepressant and anti-anxiety 
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medications such as Prozac and benzodiazepines, which 
have their own withdrawal syndromes.
THe Maine inFanT Follow-UP PRoJecT: 
evalUaTinG RiSK STaTUS in cHilDRen
The Maine infant Follow-up Project is an effort to provide a longitudinal framework to accelerate the 
early identification of developmental risk to include 
the prenatal and early infancy period so that early-early 
intervention can be initiated. To date, our work has 
included more than 00 alcohol- and opiate-exposed 
infants and involves an interdisciplinary team with 
leadership from Dr. Mark Brown, chief of pediatrics at 
eastern Maine Medical center; Dr. Paul Tisher, former 
chief of psychiatry at eastern Maine Medical center 
and chief medical officer at acadia Hospital; and the 
Maine institute for Human Genetics and Health and 
University of Maine infant development team led by 
Marie Hayes. as part of our joint efforts to identify 
high-risk infants, we have characterized both prenatal 
substance exposure and environmental risk factors in 
different samples of northeastern Maine families. in the 
first study, disadvantaged women and their infants were 
studied from pregnancy onward with the goal of under-
standing the complex relationship between infant brain 
development, demographic risk, and prenatal exposure 
to alcohol and tobacco. in the second study, we again 
evaluated demographic and alcohol/tobacco risk in the 
context of opiate addiction, with an expanded suite of 
markers of brain development. 
These two study cohorts were similarly exposed to 
rural poverty, as evidenced by their demographic char-
acteristics. Groups were also similar on measures of 
psychological wellbeing, as indicated by scores on the 
Beck Depression inventory, second edition (BDi-ii), a 
screen for maternal depression. 
in the first cohort, women were recruited from  
the Family Practice clinic (FPc) of eastern Maine 
Medical center (eMMc), which serves low-income 
families from primarily washington, Hancock, and 
Penobscot counties. Pregnant women were caucasian 
(9 percent), single (64.7 percent), young (<6 years = 
70. percent), unemployed (48 percent), and depen-
dent on Medicaid (Mainecare) or had no health insur-
ance (81.6 percent). 
The second study was conducted in a cohort of 
families enrolled in the narcotics treatment program 
(nTP) at the acadia Hospital in Bangor. The nTP 
serves primarily low-income, white families (97 
percent caucasian), ages 1 to 65, 47 percent female, 
from northeastern Maine. Mothers in this cohort were 
in recovery treatment for opiate addiction at acadia 
nTP and were maintained on methadone during 
their pregnancies. 
The groups did not differ statistically in tobacco 
use or pre-pregnancy or pregnancy estimates of alcohol 
use. Rates of tobacco and alcohol use in both samples 
were high, but similar to those of women of the same 
social class (SaMHSa 008). The two study groups 
differed primarily in opiate and other illicit drug use 
pre-pregnancy, with the acadia nTP group differing 
statistically in the use of opiates and other illicit drugs 
pre-pregnancy (opiates, marijuana, cocaine, and inhal-
ants) from the FPc group. Hence, this comparison, 
allows us to study differences in outcomes for these 
infants that are unique to opiate and other polydrug 
exposure, given the samples are similar in alcohol, 
tobacco, and environmental risk factors.  
women had structured interviews during the 
third trimester with questions about their psycholog-
ical health and the quantity, frequency, and timing  
of tobacco, alcohol and other substances both pre-
pregnancy and during pregnancy, along with ques-
tions about tolerance and addiction to alcohol. These 
measures assess problem drinking and have been 
demonstrated in the literature to be valid indicators  
of the amount and severity of prenatal exposure 
(Jacobson and Jacobson 1996). alcohol has well- 
established detrimental effects on brain development 
known as fetal alcohol syndrome/alcohol-related 
neurodevelopmental disorder (FaS/aRnD) (May  
and Gossage 001). additionally, data from routine 
random urine analyses (Ua), which screen for mari-
juana, methadone, oxycodone, other opiates, benzodi-
azepines, cocaine, and stimulant medications were 
collected. The most commonly detected illicit drug 
detected in Ua screens was marijuana, followed by 
benzodiazepines and other opiates. 
The first study found that infants whose mothers 
had high alcohol use patterns before and during preg-
nancy exhibited fragmented and unstable sleep along 
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with fewer normal sleep movements. 
infants were sleep deprived, indicated 
by decreased alertness and increased irri-
tability during the day. Tobacco 
smoking during pregnancy, present in 
54 percent of the mothers, was associ-
ated with increased infant drowsiness 
associated with difficult transitions 
between sleeping and waking. Sleep 
deprivation represents an enormous  
risk to the developing infant; sleep 
integrity is critical in brain maturation 
and plasticity, but more importantly, 
sleep deprivation is associated with 
SiDS (for a more complete discussion, 
see Hayes et al. 007).
in the second study, led by Dr. 
Brown, an interdisciplinary team of 
doctors, nurses and researchers evalu-
ated the effects of different drug  
regimens on length of hospital stay, 
withdrawal severity, and infant irrita-
bility. Between 60 and 80 percent of 
opiate-exposed infants develop a condition called 
neonatal abstinence syndrome (naS), a life-threaten-
ing collection of physiological symptoms of withdrawal 
(e.g., irritability, poor sleep and feeding, gastrointestinal 
distress, sweating and respiratory dysfunction) between 
48 and 7 hours after birth. Sixty-six percent of infants 
in the study group experienced severe withdrawal 
symptoms that met criteria for naS. 
Figure 1 shows differences in withdrawal treatment 
based on type of addiction treatment during pregnancy. 
infant outcome is measured in number of infants 
requiring no treatment, phenobarbitol, or opiate 
replacement, e.g., DTo (titrated dose of tincture of 
opium) or methadone. Mothers were treated with 
either methadone, bupenorphine (Subutex), prescrip-
tion opiates, or no treatment (self-medication or using 
street drugs). while it appears that infants of mothers 
maintained on methadone were more likely to need 
more aggressive treatment for naS (higher rates of 
DTo/methadone), it should be noted that methadone-
treated mothers generally have more complex and 
longer-standing opiate addiction and other sociodemo-
graphic challenges than those on buprenorphine.
The differences seen in infant outcome based on 
treatment history highlight the importance of charac-
terizing both the exposure history and the withdrawal 
profile of these high-risk infants. Managing and 
reducing the severity of naS through new drug regi-
mens have been implemented and have improved 
treatment and reduced the length of stay in the 
hospital. in the neonatal nursery at eMMc, mothers 
are strongly encouraged to breastfeed because of the 
demonstrated advantages for the high-risk infant’s 
developing brain and the evidence from our group and 
others that withdrawal may be ameliorated by the trace 
amounts of opiates present in the breast milk (abdel-
latif et al. 006).
as part of the opiate study, the University of 
Maine team in collaboration with Dr. Krishnan has 
been examining opiate-exposed infants and matched 
controls for early cognitive function. over the last 
decade, the behavioral and neural biomarkers to screen 
for cognitive developmental risk in the newborn using 
electroencephalography (eeG) cognitive testing have 
emerged (Molfese 000). we found that newborn brain 
waves are predicted by prenatal exposure profiles: 
FIGURE 1: Treatment rate for Neonatal Abstinence syndrome,  
 by Prenatal exposure (November 2007–November 2008)
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women entering opiate-replacement treatment earlier 
have infants with better eeG associated with attention 
and memory function. in addition, withdrawal severity 
and drug replacement clearly impair the brain eeG 
response acutely, and perhaps for the long term, adding 
new urgency for improved pharmacological regimens 
for withdrawal treatment and prenatal maternal opiate 
management (Krishnan et al. 008). 
Because the population of opiate-addicted mothers 
is characterized as having poor access to health care 
resources, integrating child screens into narcotics treat-
ment programs can activate mechanisms for early inter-
vention. Under the leadership of Dr. Tisher, and in 
conjunction with the well child clinic at acadia 
Hospital, the study team has established a follow-up 
clinic to evaluate long-term developmental conse-
quences of naS. children are assessed at seven months 
using the Bayley Scales of infant Development, which 
assesses motor, cognitive, and language development 
along with social and emotional functioning. in our 
current cohort, 50 percent of the children screened 
exhibit significant delays in motor function, an infancy 
marker of developmental delay. The relationship to 
withdrawal severity, prenatal methadone dose, and 
other prenatal and postnatal risk factors are suggestive 
but not yet clear.
Discussion 
clearly, early-early assessment is needed to 
improve pharmacological methods of prenatal metha-
done maintenance and safe withdrawal after birth, and 
to inform standards of care for these children who are 
at high risk of brain injury as they age. These current 
efforts to address the opiate crisis in the eastern Maine 
area have required tremendous focused adaptation from 
our existing health care infrastructure. The cutting-edge 
intervention system at acadia Hospital is continuing to 
develop innovative care of the pregnant patient and her 
family in preparation for the birth of the opiate-
exposed infant. There are prenatal parenting groups 
along with joint pediatric and nTP prenatal meetings 
with health care providers to prepare for hospitalization 
withdrawal complications. additionally, the psycholog-
ical adjustment to the birth of an infant, and often to 
first parenthood, is difficult for any mother, but is 
particularly difficult for a mother struggling with 
addiction recovery and economic stress. in addition to 
the typical challenges encountered by new parents, 
these families are also presented with the challenge of 
caring for a “temperamental” infant who suffers symp-
toms of withdrawal. 
FUTURe DiRecTionS anD Policy 
iMPlicaTionS
although modern medicine and intensive care interventions for newborns have revolutionized 
pediatric medicine, more efforts are needed to rehabili-
tate children suffering neurodevelopmental compro-
mise. a large proportion of these complications are 
related to poor maternal prenatal health and substance 
abuse, often leading to aRnD and in rare cases, FaS 
and naS related to opiate withdrawal. Brain injury 
learning disabilities related to alcohol exposure show up 
in the child as social and cognitive processing deficits 
and attention-deficit hyperactivity disorder. in Maine, 
prescription opiate addiction has been added to the 
problem of alcohol abuse as a risk factor in early devel-
opment. The brain developmental injury from these 
prenatal exposures conspires with environmental risk 
due to poverty to create more Maine children each year 
in need of special care, which if delayed until school-
age, may lead to a lifetime of developmental disability. 
High-risk infants are born to high-risk families 
living in high-risk environments. often, developmental 
consequences show “sleeper” effects that emerge later in 
the toddler and childhood years; that is, apparently 
healthy infants may emerge as impaired at later points 
in their lives. Hence, environmental risk factors may 
Pushing back the window of child  
identification to the perinatal and early 
infancy period allows interventionists  
to take best advantage of the explosion  
of brain growth in the first three years.
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exacerbate preexisting prenatal risk factors when the 
child returns home. 
The Maine infant Follow-up Project is now 
working in collaboration with the national effort of the 
Sarah Jane Foundation called the “Pediatric acquired 
Brain injury [PaBi] Plan” of intervention for brain 
injury during the early years (www.thebrainproject.org). 
Using cutting-edge assessment and treatment methods, 
we can identify at-risk children earlier. Pushing back the 
window of child identification to the perinatal and early 
infancy period allows interventionists to take best advan-
tage of the explosion of brain growth in the first three 
years (als et al. 004). 
it is well known that stimulating experiences and 
opportunities to practice new abilities in all develop-
mental domains (e.g., cognitive, language, social, and 
motor) optimize brain development. Targeted early envi-
ronmental enrichment that is maternal and family based 
is being implemented to increase the chance of develop-
mental catch-up and recovery, led through an expansion 
of existing developmental care systems. This dynamic 
intervention model is based on new research in pediat-
rics, developmental psychology/psychiatry, and clinical 
neuroscience tied to the PaBi national program for 
child brain injury. a statewide effort to improve early-
early assessment and intervention promises a larger net 
for developmental catch-up, along with improved family 
and school support for caregivers working with children 
with brain injury.    
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